Previous close | 0.5234 |
Open | 0.5300 |
Bid | 0.5382 x 1100 |
Ask | 0.5572 x 200 |
Day's range | 0.5250 - 0.5896 |
52-week range | 0.2900 - 1.6700 |
Volume | |
Avg. volume | 2,296,400 |
Market cap | 116.488M |
Beta (5Y monthly) | 1.40 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
RICHMOND, Calif., May 09, 2024--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS
RICHMOND, Calif., May 09, 2024--Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
RICHMOND, Calif., May 02, 2024--Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast